Literature DB >> 22217512

Epithelial-mesenchymal transition in the pathophysiology of airway remodelling in asthma.

Tillie-Louise Hackett1.   

Abstract

PURPOSE OF REVIEW: We currently understand little about the mechanisms that lead to airway remodeling in asthma. The origin of the mesenchymal cells that contribute to fibrosis of the airway is poorly understood. However, emerging evidence suggests that the airway epithelium could contribute to airway remodeling through the process of epithelial-mesenchymal transition (EMT) following environmental challenge. In this review, we will discuss the mechanistic features of EMT and highlight recent descriptions of EMT in the airway to further define the role of the airway epithelium in the pathogenesis of asthma. RECENT
FINDINGS: Growth factors, inflammatory mediators, and matricellular proteins expressed following exposure to environmental insults are known to induce downregulation of epithelial cell-cell adhesions and promote mesenchymal gene expression programs both in vitro and in vivo. These results demonstrate that the plastic and dynamic airway epithelium may contribute to airway remodeling via EMT in asthma.
SUMMARY: It is becoming increasingly clear that the airway epithelium orchestrates inflammatory and remodeling responses of the airway. Understanding the regulatory mechanisms involved in epithelial plasticity will be crucial to determine effective therapies to halt the progression of airway remodeling in asthma.

Entities:  

Mesh:

Year:  2012        PMID: 22217512     DOI: 10.1097/ACI.0b013e32834ec6eb

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  75 in total

Review 1.  Take the Wnt out of the inflammatory sails: modulatory effects of Wnt in airway diseases.

Authors:  Sebastian Reuter; Hendrik Beckert; Christian Taube
Journal:  Lab Invest       Date:  2015-11-23       Impact factor: 5.662

2.  Lyn mitigates mouse airway remodeling by downregulating the TGF-β3 isoform in house dust mite models.

Authors:  Guoping Li; John Fox; Zhigang Liu; Jun Liu; George F Gao; Yang Jin; Hongwei Gao; Min Wu
Journal:  J Immunol       Date:  2013-10-14       Impact factor: 5.422

3.  Type II Epithelial-Mesenchymal Transition Upregulates Protein N-Glycosylation To Maintain Proteostasis and Extracellular Matrix Production.

Authors:  Jing Zhang; Mohammad Jamaluddin; Yueqing Zhang; Steven G Widen; Hong Sun; Allan R Brasier; Yingxin Zhao
Journal:  J Proteome Res       Date:  2019-08-28       Impact factor: 4.466

4.  Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.

Authors:  Min-Kyung Kang; Sin-Hye Park; Yean-Jung Choi; Daekeun Shin; Young-Hee Kang
Journal:  J Mol Med (Berl)       Date:  2015-06-11       Impact factor: 4.599

Review 5.  Roles of Periostin in Respiratory Disorders.

Authors:  Kenji Izuhara; Simon J Conway; Bethany B Moore; Hisako Matsumoto; Cecile T J Holweg; John G Matthews; Joseph R Arron
Journal:  Am J Respir Crit Care Med       Date:  2016-05-01       Impact factor: 21.405

6.  Activated alveolar epithelial cells initiate fibrosis through secretion of mesenchymal proteins.

Authors:  Jibing Yang; Sarah E Wheeler; Miranda Velikoff; Kathryn R Kleaveland; Michael J LaFemina; James A Frank; Harold A Chapman; Paul J Christensen; Kevin K Kim
Journal:  Am J Pathol       Date:  2013-09-05       Impact factor: 4.307

Review 7.  Asthma therapy and its effect on airway remodelling.

Authors:  Rachid Berair; Christopher E Brightling
Journal:  Drugs       Date:  2014-08       Impact factor: 9.546

8.  TGF-β1 stimulates epithelial-mesenchymal transition mediated by ADAM33.

Authors:  Liping Fang; Jie Wu; Tao Huang; Pengpeng Zhang; Xiaofeng Xin; Yi Shi
Journal:  Exp Ther Med       Date:  2017-11-10       Impact factor: 2.447

9.  The control of tissue fibrosis by the inflammatory molecule LIGHT (TNF Superfamily member 14).

Authors:  Rana Herro; Michael Croft
Journal:  Pharmacol Res       Date:  2015-12-31       Impact factor: 7.658

10.  Altered microRNA profiles in bronchoalveolar lavage fluid exosomes in asthmatic patients.

Authors:  Bettina Levänen; Nirav R Bhakta; Patricia Torregrosa Paredes; Rebecca Barbeau; Stefanie Hiltbrunner; Joshua L Pollack; C Magnus Sköld; Magnus Svartengren; Johan Grunewald; Susanne Gabrielsson; Anders Eklund; Britt-Marie Larsson; Prescott G Woodruff; David J Erle; Åsa M Wheelock
Journal:  J Allergy Clin Immunol       Date:  2013-01-16       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.